Jeffrey Wasserstein

Senior Advisor

New York

Mr. Wasserstein joined Greenhill in 2012. He principally advises clients in the pharmaceutical, biotech, specialty pharma and generic sectors.

Prior to joining Greenhill, Jeff was a senior executive in corporate development and commercial operating roles for a series of global pharmaceutical companies including Nycomed, Fougera, Dr. Reddy’s and Schering-Plough. Prior to that, he practiced M&A and securities law at Wachtell, Lipton, Rosen & Katz in New York. He has over 35 years of experience in healthcare M&A, including licensing, joint ventures and other partnering as both an M&A advisor and principal.

Jeff holds a JD from the New York University School of Law and a BA from Franklin & Marshall College.